Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)

South Korea · Delayed Price · Currency is KRW

26,650

-100 (-0.37%)

Sep 11, 2026, 3:30 PM KST

Daihan Pharmaceutical Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	216,554	208,614	204,195	195,911	184,268	171,463
Revenue Growth	4.28%	2.16%	4.23%	6.32%	7.47%	3.24%
Gross Profit	63,722	64,445	69,407	65,312	59,812	55,682
Operating Income	30,147	31,186	38,081	35,795	32,968	29,068
Net Income	27,528	27,644	33,759	28,426	24,961	22,670
Earnings Per Share	-	4701.33	5741.34	4834.41	4170.67	3778.40
EPS Growth	-	-18.11%	18.76%	15.92%	10.38%	30.43%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	114,745	89,535	77,237	104,359	97,607	96,415
Total Debt	47.95	13.26	29.03	-	6,500	23,517
Net Cash (Debt)	114,697	89,522	77,208	104,359	91,107	72,899
Net Cash Growth	16.31%	15.95%	-26.02%	14.55%	24.98%	87.68%
Net Cash Per Share	-	15224.79	13130.53	17748.21	15223.16	12149.75

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	37,333	25,604	35,643	38,860	28,999	40,617
Capital Expenditures	-17,168	-25,123	-15,801	-21,280	-8,621	-11,850
Free Cash Flow	20,165	481.53	19,841	17,580	20,378	28,767
Free Cash Flow Growth	46.37%	-97.57%	12.86%	-13.73%	-29.16%	1.77%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	29.43%	30.89%	33.99%	33.34%	32.46%	32.48%
Operating Margin	13.92%	14.95%	18.65%	18.27%	17.89%	16.95%
Pretax Margin	15.21%	15.89%	20.73%	18.75%	18.15%	17.75%
Profit Margin	12.71%	13.25%	16.53%	14.51%	13.55%	13.22%
FCF Margin	9.31%	0.23%	9.72%	8.97%	11.06%	16.78%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	5.69	6.22	4.56	5.74	7.36	7.60
P/FCF Ratio	7.77	357.17	7.76	9.28	9.01	5.99
PS Ratio	0.72	0.82	0.75	0.83	1.00	1.00